Relative to coronary artery disease, peripheral artery disease is an undertreated and under-investigated condition. The majority of the evidence base in the management of PAD is extrapolated from data subsets of large trials examining different conditions. This creates a paucity of management decisions based on trials powered for outcomes in PAD.
Mineok Chang, Cheol Whan Lee, Jung‐Min Ahn, Rafael Cavalcante, Yohei Sotomi, Yoshinobu Onuma, Minkyu Han, Seong‐Wook Park, Patrick W. Serruys, Seung‐Jung Park
Grégoire Detriche, Grégoire Detriche, Alexis F. Guédon, Alexis F. Guédon, Nassim Mohamedi, Nassim Mohamedi, Olfa Sellami, Olfa Sellami, Charles Cheng, Charles Cheng, A. Galloula, A. Galloula, Guillaume Goudot, Guillaume Goudot, Lina Khider, Lina Khider, Hélène Mortelette, Hélène Mortelette, Jonas Sitruk, Jonas Sitruk, Nicolas Gendron, Nicolas Gendron, ,
Daisy G.M Bloemenkamp, Willem P.Th.M. Mali, Bea C. Tanis, Frits R. Rosendaal, Maurice A. A. J. van den Bosch, Jeanet M. Kemmeren, Ale Algra, Jacobus M. Ossewaarde, Frank L.J. Visseren, Anton M. van Loon, Yolanda van der Graaf
J. J. F. Belch, Eric J. Topol, Giancarlo Agnelli, Michel Bertrand, Robert M. Califf, Denis Clément, Mark A. Creager, J. Donald Easton, James R. Gavin, Philip Greenland, Graeme J. Hankey, Peter Hanrath, Alan T. Hirsch, Sidney C. Smith, Frank Sullivan, Michael A. Weber
Discussion(0)
No comments yet. Be the first to comment.